118 related articles for article (PubMed ID: 36706479)
1. TPGS decorated NLC shift gefitinib from portal absorption into lymphatic delivery: Intracellular trafficking, biodistribution and bioavailability studies.
Harisa GI; Sherif AY; Alanazi FK; Ali EA; Omran GA; Nasr FA; Attia SM; Alqahtani AS
Colloids Surf B Biointerfaces; 2023 Mar; 223():113148. PubMed ID: 36706479
[TBL] [Abstract][Full Text] [Related]
2. Engineered Nanoscale Lipid-Based Formulation as Potential Enhancer of Gefitinib Lymphatic Delivery: Cytotoxicity and Apoptotic Studies Against the A549 Cell Line.
Sherif AY; Harisa GI; Alanazi FK; Nasr FA; Alqahtani AS
AAPS PharmSciTech; 2022 Jul; 23(6):183. PubMed ID: 35773422
[TBL] [Abstract][Full Text] [Related]
3. Optimization of Gefitinib-Loaded Nanostructured Lipid Carrier as a Biomedical Tool in the Treatment of Metastatic Lung Cancer.
Sherif AY; Harisa GI; Shahba AA; Alanazi FK; Qamar W
Molecules; 2023 Jan; 28(1):. PubMed ID: 36615641
[TBL] [Abstract][Full Text] [Related]
4. Enhanced Codelivery of Gefitinib and Azacitidine for Treatment of Metastatic-Resistant Lung Cancer Using Biodegradable Lipid Nanoparticles.
Elzayat EM; Sherif AY; Nasr FA; Attwa MW; Alshora DH; Ahmad SF; Alqahtani AS
Materials (Basel); 2023 Jul; 16(15):. PubMed ID: 37570067
[TBL] [Abstract][Full Text] [Related]
5. PEGylated SLN as a Promising Approach for Lymphatic Delivery of Gefitinib to Lung Cancer.
Sherif AY; Harisa GI; Alanazi FK; Nasr FA; Alqahtani AS
Int J Nanomedicine; 2022; 17():3287-3311. PubMed ID: 35924261
[TBL] [Abstract][Full Text] [Related]
6. Topical anesthesia therapy using lidocaine-loaded nanostructured lipid carriers: tocopheryl polyethylene glycol 1000 succinate-modified transdermal delivery system.
Zhao X; Sun Y; Li Z
Drug Des Devel Ther; 2018; 12():4231-4240. PubMed ID: 30587919
[TBL] [Abstract][Full Text] [Related]
7. Assembly of nanostructured lipid carriers loaded gefitinib and simvastatin as hybrid therapy for metastatic breast cancer: Codelivery and repurposing approach.
Sherif AY; Harisa GI; Shahba AA; Nasr FA; Taha EI; Alqahtani AS
Drug Dev Res; 2023 Nov; 84(7):1453-1467. PubMed ID: 37519092
[TBL] [Abstract][Full Text] [Related]
8. Baicalin-loaded PEGylated lipid nanoparticles: characterization, pharmacokinetics, and protective effects on acute myocardial ischemia in rats.
Zhang S; Wang J; Pan J
Drug Deliv; 2016 Nov; 23(9):3696-3703. PubMed ID: 27749105
[TBL] [Abstract][Full Text] [Related]
9. Enhancing breast cancer treatment: Comprehensive study of gefitinib-loaded poloxamer 407/TPGS mixed micelles through design, development, in-silico modelling, In-Vitro testing, and Ex-Vivo characterization.
Chary PS; Bansode A; Rajana N; Bhavana V; Singothu S; Sharma A; Guru SK; Bhandari V; Mehra NK
Int J Pharm; 2024 May; 657():124109. PubMed ID: 38626846
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics and Biodistribution of Thymoquinone-loaded Nanostructured Lipid Carrier After Oral and Intravenous Administration into Rats.
Zakarial Ansar FH; Latifah SY; Wan Kamal WHB; Khong KC; Ng Y; Foong JN; Gopalsamy B; Ng WK; How CW; Ong YS; Abdullah R; Aziz MY
Int J Nanomedicine; 2020; 15():7703-7717. PubMed ID: 33116496
[TBL] [Abstract][Full Text] [Related]
11. QbD aided development of ibrutinib-loaded nanostructured lipid carriers aimed for lymphatic targeting: evaluation using chylomicron flow blocking approach.
Rangaraj N; Pailla SR; Shah S; Prajapati S; Sampathi S
Drug Deliv Transl Res; 2020 Oct; 10(5):1476-1494. PubMed ID: 32519202
[TBL] [Abstract][Full Text] [Related]
12. Superiority of TPGS-loaded micelles in the brain delivery of vinpocetine via administration of thermosensitive intranasal gel.
Ahmed TA; El-Say KM; Ahmed OA; Aljaeid BM
Int J Nanomedicine; 2019; 14():5555-5567. PubMed ID: 31413562
[No Abstract] [Full Text] [Related]
13. Development and optimization of sulforaphane-loaded nanostructured lipid carriers by the Box-Behnken design for improved oral efficacy against cancer: in vitro, ex vivo and in vivo assessments.
Soni K; Rizwanullah M; Kohli K
Artif Cells Nanomed Biotechnol; 2018; 46(sup1):15-31. PubMed ID: 29183147
[TBL] [Abstract][Full Text] [Related]
14. Development of D-α-Tocopherol polyethylene glycol 1000 succinate fabricated nanostructural lipid carrier of sorafenib tosylate for metastatic colorectal targeting application: Stability, physical characterization, cytotoxicity, and apoptotic studies against SW48 cells PTEN.
Bhattacharya S; Sharma S; Prajapati BG
Front Oncol; 2022; 12():990841. PubMed ID: 36387097
[TBL] [Abstract][Full Text] [Related]
15. Co-Delivery Anticancer Drug Nanoparticles for Synergistic Therapy Against Lung Cancer Cells.
Shen Y; TanTai J
Drug Des Devel Ther; 2020; 14():4503-4510. PubMed ID: 33122893
[TBL] [Abstract][Full Text] [Related]
16. Application of Statistical Tooling Techniques for Designing of Carvedilol Nanolipid Transferosomes and its Dermatopharmacokinetic and Pharmacodynamic Studies.
Selvaraj BR; Sridhar SK; Kesavan BR; Palagati S
Pharm Nanotechnol; 2020; 8(6):452-470. PubMed ID: 32988361
[TBL] [Abstract][Full Text] [Related]
17. Uniform carboxymethyl chitosan-enveloped Pluronic F68/poly(lactic-co-glycolic acid) nano-vehicles for facilitated oral delivery of gefitinib, a poorly soluble antitumor compound.
Wang J; Wang F; Li X; Zhou Y; Wang H; Zhang Y
Colloids Surf B Biointerfaces; 2019 May; 177():425-432. PubMed ID: 30798063
[TBL] [Abstract][Full Text] [Related]
18. Novel Gefitinib Formulation with Improved Oral Bioavailability in Treatment of A431 Skin Carcinoma.
Godugu C; Doddapaneni R; Patel AR; Singh R; Mercer R; Singh M
Pharm Res; 2016 Jan; 33(1):137-54. PubMed ID: 26286185
[TBL] [Abstract][Full Text] [Related]
19. Integrating the drug, disulfiram into the vitamin E-TPGS-modified PEGylated nanostructured lipid carriers to synergize its repurposing for anti-cancer therapy of solid tumors.
Banerjee P; Geng T; Mahanty A; Li T; Zong L; Wang B
Int J Pharm; 2019 Feb; 557():374-389. PubMed ID: 30610896
[TBL] [Abstract][Full Text] [Related]
20. Enhancement of S(+)-zaltoprofen oral bioavailability using nanostructured lipid carrier system.
Pham TMA; Lee DH; Na YG; Jin M; Jung M; Kim HE; Yoo H; Won JH; Lee JY; Baek JS; Han SC; Lee HK; Cho CW
Arch Pharm Res; 2022 Nov; 45(11):822-835. PubMed ID: 36307644
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
